{"id":196501,"date":"2025-09-03T09:48:13","date_gmt":"2025-09-03T09:48:13","guid":{"rendered":"https:\/\/www.europesays.com\/us\/196501\/"},"modified":"2025-09-03T09:48:13","modified_gmt":"2025-09-03T09:48:13","slug":"zanskar-raises-rs-2-8-crore-in-seed-funding","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/196501\/","title":{"rendered":"Zanskar raises Rs 2.8 crore in seed funding"},"content":{"rendered":"<p>GURUGRAM: Zanskar, a pain-care focused brand, has raised rS 2.8 crore in a seed round of funding led by <a ref=\"dofollow\" data-ga-onclick=\"Inarticle articleshow link click#SME#href\" href=\"https:\/\/m.economictimes.com\/topic\/zeropearl-vc\" target=\"_blank\" rel=\"nofollow noopener\">Zeropearl VC<\/a>, with participation from angel investors Pawan Gupta (Founder, Fashinza), Amit Baid (Managing Partner, 10X Growth Ventures), and Nidhish Mundra (SVP, Oaktree Capital).<\/p>\n<p>The funds will be deployed to expand Zanskar\u2019s product portfolio, scale up marketing across digital platforms, and enhance distribution through both D2C and offline retail channels. A portion of the capital will also be invested in building a dedicated R&amp;D vertical focused on chronic pain and recovery.<\/p>\n<p>According to industry sources, India\u2019s pain-relief market, covering sprays, creams, and pills, has more than doubled in the last five years to around Rs 16,000 crore ($2 billion). Analgesics and topical rubefacients alone surged from Rs 6,820 crore in 2020 to nearly Rs 15,905 crore in 2025, growing at an annual rate of 18%, almost three times faster than the overall OTC market. <br \/>Anshul Mittal &amp; Manu Mittal, Co-founders of Zanskar, jointly said in a statement, \u201cThis round is a huge validation of our belief that pain relief doesn\u2019t need to come with a trade-off. We\u2019re excited to partner with Zeropearl to take Zanskar to more homes across India and continue building products that actually work and that people love using.\u201d<\/p>\n<p>Bipin Shah, Managing Partner, Zeropearl VC, said in a statement, \u201cAt Zeropearl, we look for brands that are solving real &amp; deep problems with authenticity &amp; innovation. Zanskar\u2019s approach to pain care by combining science with empathy really stood out of the box for us. We believe the team is well-positioned to build a trusted and scalable brand in a category that impacts millions of people in India and overseas.\u201d<\/p>\n<p>Add <img decoding=\"async\" alt=\"ET Logo\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/08\/123467569.cms.png\"\/> as a Reliable and Trusted News Source<\/p>\n","protected":false},"excerpt":{"rendered":"GURUGRAM: Zanskar, a pain-care focused brand, has raised rS 2.8 crore in a seed round of funding led&hellip;\n","protected":false},"author":3,"featured_media":196502,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[64,607,109247,109248,109246,4500,67,132,68,109245,109249,77413],"class_list":{"0":"post-196501","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-entrepreneurship","8":"tag-business","9":"tag-entrepreneurship","10":"tag-india-pain-relief-market","11":"tag-otc-market-growth","12":"tag-pain-care-brand","13":"tag-seed-funding","14":"tag-united-states","15":"tag-unitedstates","16":"tag-us","17":"tag-zanskar-funding","18":"tag-zanskar-rd-investments","19":"tag-zeropearl-vc"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115139740366543787","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/196501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=196501"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/196501\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/196502"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=196501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=196501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=196501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}